LFMD LifeMD

Conversion Labs, Inc. engages in the manufacturing, distribution, and sale of natural immune support products containing proprietary yeast beta glucans. Its products are oral intake tablets and topical creams, and gels for skin application. It operates through the Finished Cosmetic Products and Nutraceutical and Cosmetic Additives segments. The company was founded in 1987 and is headquartered in New York, NY.
Company profile
Ticker
LFMD, CVLB
Exchange
Website
CEO
Justin Schreiber
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
CONVERSION LABS, INC., Immudyne, Inc.
SEC CIK
Corporate docs
LFMD stock data
()
News
Press releases
LifeMD Launches NavaMD™ Adding Direct-to-Patient Clinical Skincare Services to its Portfolio of Personalized Telehealth Brands
7 Apr 21
LifeMD Reports Q4 2020 Revenue up 227% to Record $12.9 Million, Full Year up 199% to Record $37.3 Million
29 Mar 21
LifeMD, Inc. to Host Earnings Call
29 Mar 21
LifeMD to Host Fourth Quarter and Full Year 2020 Conference Call on Monday, March 29, 2021 at 4:30 p.m. ET
17 Mar 21
LifeMD Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
16 Mar 21
Investment data
Securities sold
Number of investors
Calendar
30 Mar 21
11 Apr 21
31 Dec 21
Financial summary
Quarter (USD) |
Dec 20 | Sep 20 | Jun 20 | Mar 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) |
Dec 20 | Dec 19 | Dec 18 | Dec 17 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Financial data from LifeMD earnings reports.
Cash burn rate (estimated) | Burn method: Change in cash | Burn method: Operating income/loss | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 9.18M | 9.18M | 9.18M | 9.18M | 9.18M | 9.18M |
Cash burn (monthly) | (positive/no burn) | (positive/no burn) | 11.2M | 4.95M | 2.18M | 1.01M |
Cash used (since last report) | n/a | n/a | 37.79M | 16.7M | 7.35M | 3.41M |
Cash remaining | n/a | n/a | -28.61M | -7.52M | 1.83M | 5.77M |
Runway (months of cash) | n/a | n/a | -2.6 | -1.5 | 0.8 | 5.7 |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
2 Apr 21 | Dagnery Juan Manuel Pineiro | Common Stock, par value $0.001 | Grant | Aquire A | No | No | 0 | 10,000 | 0 | 142,182 |
2 Apr 21 | Dagnery Juan Manuel Pineiro | Common Stock, par value $0.001 | Option exercise | Aquire M | No | No | 17.26 | 4,262 | 73.56K | 132,182 |
2 Apr 21 | Dagnery Juan Manuel Pineiro | Options to purchase Common Stock Common Stock, par value $0.001 | Option exercise | Dispose M | No | No | 17.26 | 4,262 | 73.56K | 0 |
25 Feb 21 | Brad Michael Roberts | Common Stock, par value $0.001 | Buy | Aquire P | No | No | 20.5 | 5,000 | 102.5K | 5,000 |
25 Feb 21 | Eric Harold Yecies | Common Stock, par value $0.001 | Buy | Aquire P | No | No | 20.29 | 1,500 | 30.44K | 5,000 |
25 Feb 21 | Eric Harold Yecies | Common Stock, par value $0.001 | Buy | Aquire P | No | No | 19.99 | 3,500 | 69.97K | 3,500 |
24 Feb 21 | Walters Happy David | Common Stock, par value $0.001 | Other | Aquire J | No | No | 0 | 800,000 | 0 | 1,336,300 |
24 Feb 21 | Walters Happy David | Common Stock, par value $0.001 | Grant | Aquire A | Yes | No | 0 | 1,200,000 | 0 | 1,200,000 |
9 Feb 21 | Dagnery Juan Manuel Pineiro | Common Stock, par value $0.001 | Option exercise | Aquire M | No | No | 26.65 | 59,421 | 1.58M | 127,920 |
9 Feb 21 | Dagnery Juan Manuel Pineiro | Common Stock, par value $0.001 | Option exercise | Aquire M | No | No | 26.65 | 13,874 | 369.74K | 68,499 |
Institutional ownership Q1 2021
Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.
13F holders |
Current |
---|---|
Total holders | 0 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares |
Current |
---|---|
Total value | 0 |
Total shares | 0 |
Total puts | 0 |
Total calls | 0 |
Total put/call ratio | – |
Largest owners |
Shares | Value |
---|
Financial report summary
?Content analysis
?
Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
abide, acclaim, accommodate, accustomed, acute, Aesthetic, allegedly, array, arriving, article, assumption, attainment, audio, AWS, bad, band, Benathen, Blue, bona, book, breakthrough, bribery, bridge, broader, Bryant, BTIG, budget, burden, burn, cadence, CAGR, calamity, campaign, capable, CCO, CCPA, cemented, certainty, Chase, cheaper, CM, commensurate, competitor, concierge, conflicting, confusion, contest, contra, contradictory, convince, COO, Corey, correspondingly, corrupt, corruption, coupled, CPRA, culture, CVLBPR, cyclical, debarment, degradation, departure, deployment, deter, deterring, Deutsch, diagnose, digestive, diligence, disbursement, disinterested, dispersed, dissatisfied, dissolved, distraction, distrust, domestic, domestically, downturn, drop, duration, ease, easily, ecommerce, Elanor, element, embedded, enrollment, entry, eventually, expedite, expedited, Expenditure, explicitly, FCPA, fide, fiduciary, finite, FINRA, flexible, flux, forfeited, forgivable, forgiven, freestanding, frustration, fullest, gather, greatly, Greenville, hand, hinder, Horizon, host, Hussey, illegal, immaterial, impede, impeded, implicit, implied, improperly, incomplete, incumbent, indemnification, indeterminate, ineligible, infeasible, injure, inorganic, input, iNRWellnessMD, insignificant, instability, intense, intensely, intensive, intercompany, JDM, landscape, laundering, lawfully, lawsuit, leader, leadership, leave, leaving, LFMD, liable, licenseed, lifemd, lifestyle, lifted, lost, lure, machinery, macroeconomic, mainstream, mandate, Marc, Mariano, match, mercy, metric, mezzanine, micro, Milestone, misconduct, mobile, modality, motivate, motivation, movement, multiplying, mutual, mutually, myriad, nascent, nationwide, Nava, NavaMD, necessitate, necessitated, noteholder, nurse, offline, onboard, onset, opposition, overwhelming, PA, pandemic, Panel, paper, partially, passage, Pathak, pause, Paycheck, permissible, phone, PIK, podcast, pool, poor, PPP, predetermined, print, processor, procure, prospective, protracted, Puopolo, quotient, radically, ratably, reaction, ready, recalculated, recapitalization, Reconciliation, recourse, redemption, referenced, reinforced, Relatedly, relaxation, remeasured, reorganization, repeal, replicate, repurposed, resell, resistance, resolution, Restoresea, Restorsea, restructure, Restructuring, revolutionizing, Ro, Roberto, robust, round, rounding, RSU, SBA, seizure, sexual, sexually, ShapiroMD, shortfall, Simon, simple, slightly, slowdown, South, staffed, staffing, steadily, steep, sterilization, STI, stigma, stoppage, streaming, strike, stronger, strongly, Subtopic, successor, superior, suspension, switch, takeover, talent, talented, taxation, Teledoc, territory, thereof, thereunder, thirteen, thirtieth, threatened, timetable, tranche, trillion, trustworthy, unaddressed, unaware, unclear, unearned, unforgiven, unfriendly, unimpeded, unintended, uninterrupted, unmarketable, unpaid, unregistered, unrest, unsettled, unwilling, usage, vandalism, Varun, verifying, vii, VWAP, week, workforce, worsen, Wyoming, younger
Removed:
Academy, accountant, acknowledgment, Acorn, advice, advisor, affirmatively, aggregating, Aldridge, Allen, alternate, appeal, attempt, BA, bachelor, baker, banking, BCII, Berman, bid, biographical, blockchain, Borenstein, Bornstein, broker, Brown, Bruzzese, BS, buy, calculating, capped, caption, cellular, certified, CFO, Chairman, clear, cole, College, commercialization, commercializing, community, compensated, composition, comprising, consume, copy, Councilor, County, CPA, creative, Cruse, Dartmouth, de, dealer, decided, dependence, depth, Dermatologic, dermatologist, diagnostic, Diplomate, directed, disagreement, disciplinary, dismissed, dispositive, distribution, distributional, division, doubtful, earn, effecting, Elizabethtown, employed, encourage, ending, equally, exceeding, exemption, exercising, exhausted, existed, extension, Fellow, Florida, foamer, forfeiture, forward, founder, frame, France, Gate, glucan, graduate, great, Henderson, highest, home, Hospital, Houston, ICN, identifying, imaging, IMMD, incentivized, incremental, ineffective, innovative, internship, inventor, Island, issuing, Jersey, joined, JOJ, jury, Kalkstein, Kent, label, Landmark, language, laser, lecturer, legacy, lesser, licensing, LLP, loyalty, maximum, McLaughlin, Memorial, Miami, Michael, minimum, modification, modified, molecular, Nancy, narrative, narrower, naturally, netted, nominating, North, nutraceutical, NutraTech, OneMedPlace, optimize, Palm, participant, penny, perASC, pharmacology, Pink, planning, practicing, preceding, prevail, professor, prominent, promulgated, pronouncement, question, quotation, quoted, radiologist, Radiology, ran, ratify, recipient, reimbursed, relation, relinquish, requirement, rescinded, rescission, researcher, residency, resign, resignation, resigned, retire, retrospective, reviewing, Rhode, Rich, Richmond, Robert, Roger, Rosenberg, RRBB, salesperson, School, science, scientific, Scott, secondary, settled, shared, shown, significance, skin, Society, Sorbonne, speculation, St, standardized, standing, suit, suitability, surgery, surgical, tangible, telephone, toll, UMDNJ, unavailable, undergo, University, unvested, upheld, urology, Urovalve, vehicle, Warwick, wife, worked, worth
Financial reports
10-K
2020 FY
Annual report
30 Mar 21
10-Q
2020 Q3
Quarterly report
16 Nov 20
10-Q
2020 Q2
Quarterly report
14 Aug 20
10-Q
2020 Q1
Quarterly report
19 May 20
NT 10-Q
Notice of late quarterly filing
15 May 20
10-K
2019 FY
Annual report
30 Mar 20
10-Q
2019 Q3
Quarterly report
14 Nov 19
10-Q
2019 Q2
Quarterly report
14 Aug 19
10-Q
2019 Q1
Quarterly report
15 May 19
10-K
2018 FY
Annual report
31 Mar 19
Current reports
8-K
Unregistered Sales of Equity Securities
6 Apr 21
8-K
LifeMD Reports Q4 2020 Revenue up 227% to Record $12.9 Million, Full Year up 199% to Record $37.3 Million
1 Apr 21
8-K
Unregistered Sales of Equity Securities
26 Feb 21
8-K
Conversion Labs Begins Trading Under New Company Name, LifeMD, and Ticker Symbol, LFMD
22 Feb 21
8-K
Conversion Labs to Become Life MD™ with Launch of New Concierge Telehealth Services
12 Feb 21
8-K
Conversion Labs Appoints Seasoned Financial and Operational Executive, Marc Benathen, as Chief Financial Officer
10 Feb 21
8-K
Unregistered Sales of Equity Securities
4 Feb 21
8-K
Regulation FD Disclosure
2 Feb 21
8-K/A
Conversion Labs Increases Stake in Fast-Growing SaaS Subsidiary
28 Jan 21
8-K
Entry into a Material Definitive Agreement
26 Jan 21
Registration and prospectus
S-1/A
IPO registration (amended)
29 Dec 20
8-A12B
Registration of securities on exchange
9 Dec 20
S-1
IPO registration
25 Nov 20
D
$16M in equity / options, sold $16M, 23 investors
20 Nov 20
D
$25K in securities to be acquired, sold $25K, 1 investor
8 Sep 20
D
$3.5M in equity / options, sold $3.5M, 1 investor
8 Sep 20
424B3
Prospectus supplement
26 Mar 20
424B3
Prospectus supplement
27 Feb 20
424B3
Prospectus supplement
12 Jul 18
S-1/A
IPO registration (amended)
9 Jul 18
Proxies
DEF 14A
Definitive proxy
7 Dec 20
PRER14A
Preliminary revised proxy
3 Dec 20
PRER14A
Preliminary revised proxy
24 Nov 20
PRE 14A
Preliminary proxy
13 Oct 20
DEF 14A
Definitive proxy
16 Dec 19
PRE 14A
Preliminary proxy
6 Dec 19
DEFA14A
Additional proxy soliciting materials
21 May 18
DEFA14A
Additional proxy soliciting materials
14 May 18
DEF 14A
Definitive proxy
19 Apr 18
PRE 14A
Preliminary proxy
9 Apr 18
Other
EFFECT
Notice of effectiveness
4 Jan 21
CORRESP
Correspondence with SEC
28 Dec 20
UPLOAD
Letter from SEC
6 Dec 20
CORRESP
Correspondence with SEC
2 Dec 20
UPLOAD
Letter from SEC
1 Dec 20
UPLOAD
Letter from SEC
29 Nov 20
CORRESP
Correspondence with SEC
23 Nov 20
UPLOAD
Letter from SEC
28 Oct 20
EFFECT
Notice of effectiveness
11 Jul 18
UPLOAD
Letter from SEC
8 Jul 18
Ownership
4
LifeMD / Dagnery Juan Manuel Pineiro ownership change
7 Apr 21
4
LifeMD / Happy David Walters ownership change
24 Mar 21
SC 13D
LifeMD / Walters Happy David ownership change
19 Mar 21
4
LifeMD / Happy David Walters ownership change
26 Feb 21
4
LifeMD / Eric Harold Yecies ownership change
25 Feb 21
4
LifeMD / Brad Michael Roberts ownership change
25 Feb 21
3
CONVERSION LABS / Marc David Benathen ownership change
10 Feb 21
3
CONVERSION LABS / Corey Deutsch ownership change
5 Feb 21
3
CONVERSION LABS / Brad Michael Roberts ownership change
3 Feb 21
4
CONVERSION LABS / Justin Schreiber ownership change
2 Feb 21
Reddit threads
Daily Discussion Thread - March 29th, 2021
29 Mar 21
Most Anticipated Earnings Releases for the week beginning March 29, 2021
27 Mar 21
Daily Discussion Thread - March 26th, 2021
26 Mar 21
RXMD - Still Severely Undervalued, Catalysts Coming Soon
17 Mar 21
$LFMD DD - the short term and long term prospects of $LFMD and of the tele-health industry
4 Mar 21
LFMD - now at a very attractive entry point and good fundamentals to go long
1 Mar 21
Stocks I am personally buying
27 Feb 21
Good examples of former penny stocks that are consistently at $20+ today?
22 Feb 21
Trade Ideas for Monday - 22 Feb 2021
20 Feb 21
I get depressed when see all these stocks that have gone up like 1,000%
10 Feb 21